Business Wire

Augmented Reality: Patient Experience Trumps Misconceptions Around Injectables

Share

New global research,2 sponsored by Galderma and released today by leading filler brand Restylane®, has revealed the prevalent societal misconceptions and stereotypes facing the aesthetics industry. Forty percent of respondents admitted they would discourage others from using facial injectables to reduce wrinkles or provide volume. A further 34% said they believed the results of such treatments look fake and unnatural.

Despite holding these views, when the same respondents were presented with a range of images of people who had undergone filler treatments, the data told another story. On average, 4 out of 5 people could not always identify those who had received filler.3 This highlights the common misconceptions about these types of treatments and the results they deliver.

The perceptions surrounding the use of temporary fillers stand in stark contrast to those around the use of permanent beauty treatments such as tattoos, body piercings and dental corrections. Tattoos and body piercings are primarily seen as a positive form of self-expression (30% of respondents agreed for tattoos, and 24% for body piercings). Teeth straightening is viewed by 47% of respondents as a great way to enhance your appearance. Meanwhile, over a third of respondents (35%) believe fillers create unrealistic beauty standards and ideals, while 26% feel they can easily become addictive and 24% say they are an extreme option.

However, Restylane patient feedback data shows that 96% of people who used fillers felt their treatment exceeded expectations,4 and 95% of patients had maintained or enhanced the naturalness of their facial expressions after treatment.5,6

“This new research by Restylane highlights the perception that people are choosing procedures such as fillers because they lack confidence or are going to extremes to get their desired look. But this just isn’t the case! The vast majority of the clients I see are opting for small, subtle changes that will help them create their own look and feel empowered to be the best version of themselves. In my opinion, these people are inherently self-confident, know their own minds and are simply taking control of their own looks.”

DR. LUIZ AVELAR

PLASTIC SURGEON

BELO HORIZONTE, BRAZIL

The prevalence of societal judgements and the impact they have on how people behave are laid bare in the study. Only 11% of respondents said they would be supportive if a friend or family member told them they were considering using fillers. In contrast, according to Restylane patient feedback, 99% of those who have received treatment would recommend Restylane to a friend.4,6

Media leads in debunking misconceptions

The results also reveal that people see the media as more progressive in its views about aesthetic treatments. 27% percent of respondents said the media portrays injectables as empowering, while just 13% would personally describe them this way. Adult Gen Z7 respondents displayed a more open-minded attitude toward aesthetic procedures and were more likely to see treatments of this nature as empowering (19% in this age group agreed versus 13% overall). They were almost three times more likely to feel positively toward fillers than those over 55 years old, only 7% of whom agreed. Younger consumers also feel that people seeking injectable treatments are inherently more confident.

“I’m finding the newer generation is even more open-minded and interested when it comes to injectables. They consider aesthetic treatments to further define and enhance how they look and feel. Given that Restylane studies show that those who use dermal fillers feel overwhelmingly positive about their treatment, we are likely to see more people using them as a means of empowerment.”

STEVEN DAYAN, M.D.

FACIAL PLASTIC SURGEON, PROFESSOR AND DIRECTOR OF DENOVA RESEARCH

CHICAGO, ILLNOIS, U.S.

The research appears ahead of a Restylane product placement spot in new action-comedy film Mafia Mamma, directed by Catherine Hardwicke of Twilight fame and co-starring Toni Collette and Monica Bellucci. Mafia Mamma celebrates female empowerment and sees Toni Collette’s character challenging her comically clueless colleagues and their outdated attitudes about the reasons why women chose to undergo aesthetic treatments. While the film uses humor to highlight these stereotypes and the judgements people make about injectables, the attitudinal study highlights how these real-life judgements are still prevalent in society. Such beliefs have a tangible impact on the way people behave toward those considering fillers.

“We believe in championing everybody’s right to pursue their own beauty ideals. Our research findings are shining a spotlight on some of the misconceptions people have about aesthetic treatments. In this way, we hope to better equip people to make the decision that is right for them, without worrying about external pressures and judgements.”

GERRY MUHLE

HEAD OF GLOBAL BUSINESS UNIT, AESTHETICS

GALDERMA

About Restylane®

Restylane is the original non-animal stabilized hyaluronic acid filler with over 26 years of achievement and over 55 million treatments worldwide. NASHA™ and OBT™ technologies make Restylane the world’s most diverse range of fillers to deliver truly individualized results.4,5

The Restylane portfolio of products includes Restylane, Restylane Lyft, Restylane Kysse, Restylane Volyme, Restylane® Defyne, Restylane® Refyne, Restylane® EYELIGHT, Restylane SKINBOOSTERS VITAL and Restylane SKINBOOSTERS VITAL LIGHT.

About Galderma

Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we’re in shapes our lives, we are advancing dermatology for every skin story. For more information, visit: www.galderma.com.

Footnotes
1 Injectables are aesthetic products which are injected under the skin for a variety of reasons. These include relaxing muscles to alleviate facial wrinkles and folds, or helping contour areas of the face or body, e.g., by restoring volume or adding projection. They often come in the form of products such as botulinum toxin or HA-fillers.
2 Research was carried out by YouGov surveying 9,733 people across the UK, U.S., Canada, Brazil, Germany and Thailand between January 17 and 27, 2023.
3 Respondents were shown six images of people who had used dermal fillers and were asked to indicate if they think the person in the image had used dermal fillers.
4 Andriopoulos B, et al. Presented at: AMWC Monte Carlo, Monaco. 2019.
5 Phillipp-Dormston W, et al. J Cosmet Dermatol. 2020;19:1600–6.
6 Hilton S, et al. Dermatol Surg. 2018;44:261–9.6
7 Adult Gen Z includes those in the 18-24 age bracket.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For further information:

Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50

Sébastien Cros
Corporate Communications Director
Sebastien.cros@galderma.com
+41 79 529 59 85

Rachel Mooney
Global Franchise Communications
rachel.mooney@galderma.com
+41 76 261 64 41

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

H.I.G. Capital Announces the Sale of DGS S.p.A.11.6.2024 12:00:00 CEST | Press release

H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $62 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell its portfolio company, DGS S.p.A. (“DGS” or the “Group”), a leading firm in the Italian Information Technology market, to DGS Co-Founders and management team in partnership with ICG, a global alternative asset manager. Since its inception in 1997, DGShas supported blue-chip customers in the design, integration, and maintenance of complex IT systems, with a specialization in digital transformation and cybersecurity services. The Group currently has over 1,900 employees, revenues of approximately €300 million, and maintains a group of highly loyal clientele. During H.I.G.’s ownership, DGS has tripled in size and consolidated its position as a leading Italian firm in cybersecurity services and digital transformation. DGS offers its clients sophisticated and proprietary digital transformation

Evertas Names Nick Selby Head of European Underwriting11.6.2024 12:00:00 CEST | Press release

Evertas, the world’s first crypto insurance company, has named Nick Selby as its new Head of European Underwriting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611141887/en/ Nick Selby, Executive Vice President and Head of European Underwriting at Evertas (Photo: Business Wire) Selby, an accomplished information and physical security professional, brings two decades of expertise in public and private sector information security, physical security, and complex incident handling, as well as seven years of experience leading teams securing billions of dollars in cryptoassets. Previously, his roles included VP of the Software Assurance Practice at Trail of Bits, Chief Security Officer at Paxos Trust Company, and Director of Cyber Intelligence and Investigations at the NYPD Intelligence Bureau. “Nick is an extremely valuable addition to our European team,” said Evertas CEO and Co-Founder J. Gdanski. “His public and private

Owlet utvider globalt fotavtrykk med lanseringen av medisinsk-sertifisert Dream Sock™ i Storbritannia og over hele Europa11.6.2024 11:00:00 CEST | Pressemelding

Owlet, Inc. («Owlet» or the «Company») (NYSE:OWLT), pioneren innen smart spedbarnsovervåking, kunngjør i dag den britiske og europeiske lanseringen av Dream Sock. Dette er en smart babymonitor med levende helseavlesninger og varsler for friske spedbarn mellom 0-18 måneder og 2,5-13,6 kg. Dette innovative medisinske utstyret gir foreldre helse og viktig informasjon i sanntid, noe som gir uovertruffen trygghet. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20240611820341/no/ (Photo: Business Wire) «Vi er svært stolte over å lansere Dream Sock til omsorgspersoner over hele Storbritannia og Europa og gi millioner av foreldre mer trygghet mens babyen sover,» sa Kurt Workman, Owlets administrerende direktør og medgründer. «Dream Sock er nå et globalt produkt som er anerkjent som medisinsk nøyaktig og trygt, etter å ha gjennomgått regulatoriske autorisasjoner og sertifiseringer innenfor flere geografier. I dag er misjonen vår

V-Nova Surpasses 1000 Patent Milestone in Media Technology Innovation11.6.2024 10:00:00 CEST | Press release

V-Nova, a leading provider of data compression solutions, video compression technology, XR technology, AI acceleration and parallel processing for a multitude of industries including media and entertainment, today announced its milestone achievement of 1000 active technology patents. This accomplishment underscores V-Nova’s dedication to research and development and its commitment to protecting its intellectual property globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611724561/en/ V-Nova’s patent portfolio spans more than 50 different jurisdictions. Including over 400 patents in Europe, over 200 in the Americas, over 100 in the United States specifically, and over 200 in Asia. V-Nova forged new directions in data processing to enhance digital experiences, maximize efficiency, reduce costs, and increase sustainability. The company leads the way with key international data compression standards for the video indust

Alipay+ Reveals Top Scorer Trophy Design for UEFA EURO 2024™11.6.2024 09:24:00 CEST | Press release

Alipay+, a suite of cross-border mobile payment and digitalization technology solutions operated by Ant International and an Official Partner of UEFA EURO 2024™, today revealed the trophy that will be awarded to the most prolific marksman at the UEFA EURO 2024™ finale on July 14 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240610328619/en/ The UEFA Top Scorer Trophy presented by Alipay+ is unveiled for UEFA EURO 2024™ (Photo: Business Wire) Sculpted in the shape of the Chinese character “支” (pronounced zhi, and meaning payment as well as support), the trophy reflects Alipay+’s dedication to supporting consumers to enjoy seamless payment and a broad choice of deals using their preferred payment methods while traveling abroad. The character also resembles the fleeting moment of a barefooted striker poised to shoot, evoking the original beauty and power of football – a game that united people across the wo

World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye